BPI 2026 SERIES SIX ARTICLES

Bioprocess intelligence—from cell line development to manufacturing.

A six-part series on connecting process evidence, AI, hybrid digital twins and scientific expertise across the development lifecycle.

Publishing throughout BPI week

New articles appear automatically on their scheduled publication day. Every article remains connected through series navigation and relevant BioMedAna product resources.

AI cell line development workflow showing experimental data connected through Bio Hub and analyzed by Bio Agents to support clone selection and scientific decisions.

BPI 2026 SERIES · ARTICLE 1 OF 6 · 9 MIN READ

AI in Cell Line Development: From More Experiments to Better Decisions

The next opportunity in cell line development isn't simply generating more data. It's connecting experimental evidence, scientific context and AI to make better decisions—and carrying that knowledge forward.

Read article 1 ↗

Bioprocess scale-up from 2 L to 10,000 L showing process evidence, physics, biology and AI feeding a Bio Twin to simulate and evaluate scale-up decisions.

BPI 2026 SERIES · ARTICLE 2 OF 6 · 11 MIN READ

From Bench to Manufacturing: Using AI to De-Risk Bioprocess Scale-Up

Scale-up is not simply making the same process bigger. As bioreactor scale changes, the physical environment changes—and biology responds. Combining process data, engineering principles, biological context, AI/ML and scientific expertise can help teams understand those changes before they become manufacturing surprises.

Read article 2 ↗

Downstream purification train showing process and analytical evidence flowing through Bio Hub, Bio Agents and Bio Twin to support investigation, prediction and optimization.

BPI 2026 SERIES · ARTICLE 3 OF 6 · 9 MIN READ

From Data to Decisions: AI, PAT and Intelligent Downstream Processing

How connected process evidence, real-time analytics, intelligent agents and hybrid models can help downstream teams understand variability, optimize purification and make better-supported decisions.

Read article 3 ↗

Five-stage AI-native biomanufacturing architecture connecting process systems to Bio Hub, Bio Agents, Bio Twin and governed decision intelligence.

BPI 2026 SERIES · ARTICLE 4 OF 6 · 9 MIN READ

Beyond Dashboards: What AI-Native Biomanufacturing Actually Looks Like

Connecting process data is only the beginning. The next generation of digital biomanufacturing must turn scientific and manufacturing evidence into context, predictions, recommendations and continuously reusable process knowledge.

Read article 4 ↗

Bioprocess knowledge thread carrying experiments, evidence, models, decisions and rationale from cell line development through technology transfer, PPQ and manufacturing.

BPI 2026 SERIES · ARTICLE 5 OF 6 · 8 MIN READ

From Process Development to PPQ: Building a Digital Thread That Preserves Process Knowledge

Technology transfer should move more than documents. Connecting process evidence, models, decisions and scientific rationale can help teams carry process understanding from development through scale-up, transfer, PPQ and commercial manufacturing.

Read article 5 ↗

Ten AI use cases across bioprocess development, scale-up, operations and continuous learning, with a crawl-walk-run path to value.

BPI 2026 SERIES · ARTICLE 6 OF 6 · 8 MIN READ

Where Does AI Actually Create Value in Bioprocessing?

10 practical use cases from cell line development to commercial manufacturing—and a framework for deciding where to start.

Read article 6 ↗

← Back to all resources